Alliance Pharma PLC
LSE:APH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Alliance Pharma PLC
Cost of Revenue
Alliance Pharma PLC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Cost of Revenue
-£69.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-14%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cost of Revenue
-£8.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cost of Revenue
-$11.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-10%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cost of Revenue
-$1.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-12%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Cost of Revenue
-£27.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-8%
|
|
|
Animalcare Group PLC
LSE:ANCR
|
Cost of Revenue
-£35.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-19%
|
|
Alliance Pharma PLC
Glance View
Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).
See Also
What is Alliance Pharma PLC's Cost of Revenue?
Cost of Revenue
-69.6m
GBP
Based on the financial report for Dec 31, 2024, Alliance Pharma PLC's Cost of Revenue amounts to -69.6m GBP.
What is Alliance Pharma PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-14%
Over the last year, the Cost of Revenue growth was 8%. The average annual Cost of Revenue growth rates for Alliance Pharma PLC have been -9% over the past three years , -7% over the past five years , and -14% over the past ten years .
